tocilizumab

Documents about tocilizumab

• Pilot Study of Tocilizumab Monotherapy for Active Chronic Periaortitis#1150745ClinicalTrials.gov
• Tocilizumab in Covid-19 Penumonia in Buenos Aires City#870514ClinicalTrials.gov
• Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome#1408350ClinicalTrials.gov
• Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis#841015ClinicalTrials.gov
• Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis#885597ClinicalTrials.gov
• Tocilizumab in Children With ACP#980618ClinicalTrials.gov
• Therapeutic Drug Monitoring of Tocilizumab in Rheumatoid Arthritis#1383232ClinicalTrials.gov
• Tocilizumab Plus a Short Prednisone Taper for GCA#826725ClinicalTrials.gov
• COVID-19: Salvage TOcilizumab as a Rescue Measure#1088289ClinicalTrials.gov
• Tocilizumab in Lung Transplantation#1172958ClinicalTrials.gov
• Tocilizumab for the Treatment of Refractory Behcet's Uveitis#1280269ClinicalTrials.gov
• Ultra-short Glucocorticosteroids and Tocilizumab Therapy in GCA Patients#1362899ClinicalTrials.gov
• Atezolizumab, Bevacizumab, and Tocilizumab in Advanced Hepatocellular Carcinoma#807035ClinicalTrials.gov
• TOCILIZUMAB IN FIBROUS DYSPLASIA OF BONE#904770ClinicalTrials.gov
• Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid Arthritis#1138578ClinicalTrials.gov
• The Safety and Effectiveness of Tocilizumab in Rheumatoid Arthritis#892742ClinicalTrials.gov
• A Study of Tocilizumab and Methotrexate Treatment Strategies (Adding Tocilizumab to Methotrexate Versus Switching to Tocilizumab) in Patients With Active Rheumatoid Arthritis With Inadequate Response to Prior Methotrexate Treatment#833192ClinicalTrials.gov
• TocILizumab in aorTitis in GCA (TILT)#852426ClinicalTrials.gov
• Pilot Study of Tocilizumab in Patients With Erdheim-Chester Disease#982239ClinicalTrials.gov
• Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)#1125465ClinicalTrials.gov
• Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis#1446380ClinicalTrials.gov
• Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia#917822ClinicalTrials.gov
• An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies#1152772ClinicalTrials.gov
• Evolution of Adipokines and Body Composition in Rheumatoid Arthritis Patients Receiving Tocilizumab Therapy#1260812ClinicalTrials.gov
• Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis#1398388ClinicalTrials.gov
• An Open-Label Trial of Tocilizumab in Schizophrenia#1421438ClinicalTrials.gov
• Effect of Tocilizumab on Intensive Care Patients With COVID-19 Pneumonia, a Retrospective Cohort Study#1454228ClinicalTrials.gov
• Tocilizumab Versus Baricitinib in Patients With Severe COVID-19#1477947ClinicalTrials.gov
• Bullous Rheumatoid Neutrophilic Dermatitis in a Juvenile Idiopathic Arthritis Patient Treated With Tocilizumab#1266789Kyoto University Research Information Repository
• Bullous Rheumatoid Neutrophilic Dermatitis in a Juvenile Idiopathic Arthritis Patient Treated With Tocilizumab#1266792Kyoto University Research Information Repository
• Effect of Tocilizumab to the Cellular Immune Response to Influenza Vaccine#1396742ClinicalTrials.gov
• Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission.#858099ClinicalTrials.gov
• Tocilizumab for Cytokine Release Syndrome Prophylaxis in Haploidentical Transplantation#868964ClinicalTrials.gov
• A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab#1310075ClinicalTrials.gov
• Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome#1453891ClinicalTrials.gov
• TARGET GCAT Registry#910181ClinicalTrials.gov
• Tocilizumab in Schizophrenia#1281777ClinicalTrials.gov
• Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis#838667ClinicalTrials.gov
• A Safety and Pharmacokinetic Study of Complarate (Tocilizumab Biosimilar) and Actemra® in Healthy Volunteers#1074490ClinicalTrials.gov
• Tocilizumab for Severe COVID-19 Infection and Multisystem Inflammatory Syndrome in Adults and Children#453441Scholarly Commons
• Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)#899585ClinicalTrials.gov
• Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis#844670ClinicalTrials.gov
• Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis#1163926ClinicalTrials.gov
• A Study of Tocilizumab (RoActemra) in Tocilizumab-Naive Participants With Rheumatoid Arthritis and Inadequate Response to Non-Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) and/or Biologic Therapy#813139ClinicalTrials.gov
• Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)#916985ClinicalTrials.gov
• Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia#860283ClinicalTrials.gov
• TOcilizumab and Covid-19 : Risk of Severe INfection#1152121ClinicalTrials.gov
• Filling Bone Erosions: a Longitudinal Multicentric HR-pQCT Study of Subcutaneous Tocilizumab in Rheumatoid Arthritis#883636ClinicalTrials.gov
• COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"#890879ClinicalTrials.gov
• Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19#1475785ClinicalTrials.gov